Regulacje i polityka gospodarcza · 21/11/1996

FDA Approves Biora US, Inc.'s EMDOGAIN for Premarket Approval

The US Food and Drug Administration (FDA) has granted premarket approval for Biora US, Inc.'s EMDOGAIN, following a recommendation by the Dental Products Panel and a notification by the FDA's Center for Devices and Radiological Health (CDRH) on September 30, 1996.